The rationale of this study was based on the observation that the expression of genes associated with autophagy was downregulated, whereas genes involved in the IL-23 pathway were upregulated in liver tissue from patients with advanced NAFLD. The gene discussed is IL23A; the disease is metabolic dysfunction-associated steatotic liver disease.